Haddad, Rogerio – Trademark Portfolio

Entity Type: 01

Haddad, Rogerio holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PETIX and WIZSMART. The owner is based in São Paulo.

Unit 231

Av. Jandira 656

São Paulo 04080-004 , BR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WIZSMART
WIZSMART
Registered 2017
WIZSMART
WIZSMART
Abandoned 2017
PETIX
PETIX
Registered 2017

Trademark Classifications

Haddad, Rogerio's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Haddad, Rogerio have?

Haddad, Rogerio has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Haddad, Rogerio file in?

Haddad, Rogerio files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are Haddad, Rogerio's most well-known trademarks?

Haddad, Rogerio's registered trademark portfolio includes well-known marks such as PETIX and WIZSMART. These are among 2 currently registered trademarks in the portfolio.

What is Haddad, Rogerio's trademark registration success rate?

Haddad, Rogerio has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.